|
12 Feb 2025
|
Quarterly Results |
- |
|
11 Nov 2024
|
Quarterly Results |
- |
|
12 Aug 2024
|
Quarterly Results |
- |
|
23 May 2024
|
Audited Results |
- |
|
08 Feb 2024
|
Quarterly Results |
- |
|
04 Nov 2023
|
Quarterly Results |
- |
|
10 Aug 2023
|
Quarterly Results |
- |
|
10 May 2023
|
Audited Results |
- |
|
09 Feb 2023
|
Quarterly Results |
- |
|
01 Dec 2022
|
Others |
Inter alia, to consider and approve, amongst other things, raising of funds and issuance of securities through Qualified Institutions Placement basis. |
|
14 Nov 2022
|
Quarterly Results |
- |
|
10 Aug 2022
|
Quarterly Results |
- |
|
12 May 2022
|
Audited Results |
- |
|
12 Feb 2022
|
Quarterly Results |
- |
|
14 Nov 2021
|
Quarterly Results |
- |
|
13 Aug 2021
|
Quarterly Results |
- |
|
15 Jul 2021
|
Others |
inter-alia, to consider and approve: Fund raising by way of issuance of equity shares through preferential allotment/private placement in single/multiple tranches. |
|
22 May 2021
|
Audited Results |
- |
|
09 Feb 2021
|
Quarterly Results |
- |
|
11 Nov 2020
|
Quarterly Results |
- |
|
07 Sep 2020
|
Quarterly Results |
- |
|
29 Jun 2020
|
Audited Results |
- |
|
17 Feb 2020
|
Quarterly Results |
- |
|
14 Nov 2019
|
Quarterly Results |
- |
|
12 Aug 2019
|
Quarterly Results |
- |
|
03 Jun 2019
|
Audited Results |
(Revised) |
|
31 May 2019
|
Audited Results |
- |
|
13 Feb 2019
|
Quarterly Results |
- |
|
29 Jan 2019
|
Quarterly Results |
- |
|
30 Nov 2018
|
Quarterly Results |
By Resolution Professional |
|
21 Aug 2018
|
Audited Results |
- |
|
17 Apr 2018
|
Quarterly Results |
for the month of December 31, 2017 |
|
16 Mar 2018
|
Quarterly Results |
for fthe month of Sep' 2017 |
|
05 Mar 2018
|
Quarterly Results |
for fthe month of June' 2017 |
|
26 May 2017
|
Audited Results |
- |
|
07 Feb 2017
|
Quarterly Results |
- |
|
09 Nov 2016
|
Quarterly Results |
- |
|
13 Aug 2016
|
Quarterly Results & Others |
- |
|
27 May 2016
|
Audited Results |
- |
|
10 Feb 2016
|
Quarterly Results |
- |
|
09 Nov 2015
|
Quarterly Results |
- |
|
13 Aug 2015
|
Quarterly Results |
- |
|
28 May 2015
|
Audited Results |
- |
|
30 Mar 2015
|
Appointment of Women Director |
- |
|
13 Feb 2015
|
Quarterly Results |
- |
|
13 Nov 2014
|
Quarterly Results |
- |
|
14 Aug 2014
|
Quarterly Results |
- |
|
14 Jul 2014
|
Preferential Issue of shares |
- |
|
12 May 2014
|
Quarterly Results |
- |
|
11 Feb 2014
|
Quarterly Results |
- |
|
29 Nov 2013
|
Audited Results |
For 18 months ended september 2013.i.e from April 012012 to september 30.2013 |
|
14 Aug 2013
|
Quarterly Results |
- |
|
15 May 2013
|
Quarterly Results |
- |
|
13 Feb 2013
|
Quarterly Results |
- |
|
09 Nov 2012
|
Quarterly Results |
- |
|
14 Aug 2012
|
Quarterly Results |
- |
|
14 May 2012
|
Audited Results & Dividend |
- |
|
08 Feb 2012
|
Quarterly Results |
- |
|
07 Jan 2012
|
To consider the Merger |
To consider the proposal for Merger of its wholly owned subsidiary, Orchid Research Laboratories Ltd. with Orchid Chemicals & Pharmaceuticals Ltd. |
|
01 Nov 2011
|
Quarterly Results |
- |
|
29 Jul 2011
|
Quarterly Results |
- |
|
18 May 2011
|
Audited Results & Dividend |
- |
|
19 Jan 2011
|
Quarterly Results |
- |
|
28 Oct 2010
|
Quarterly Results |
- |
|
21 Jul 2010
|
Quarterly Results |
- |
|
27 May 2010
|
Audited Results & Dividend |
- |
|
28 Apr 2010
|
Appointment of Executive Director |
The Board has appointed Mr. S. Krishnan, Head - Finance & Business Planning as Executive Director of the Company w.e.f. April 28, 2010. |
|
29 Jan 2010
|
Quarterly Results |
- |
|
15 Dec 2009
|
Others |
To sale & transfer of its generic injectables pharmaceuticals business to Hospira, Inc., USA. The acquisition by Hospira includes Orchid's beta-lactam antibiotics manufacturing complex. |
|
30 Oct 2009
|
Quarterly Results |
- |
|
31 Jul 2009
|
Quarterly Results |
- |
|
29 Jun 2009
|
Audited Results & Dividend |
- |
|
28 Jan 2009
|
Quarterly Results |
- |
|
30 Oct 2008
|
Quarterly Results |
- |
|
30 Jul 2008
|
Quarterly Results |
- |
|
29 May 2008
|
Audited Results & Dividend |
- |
|
17 Jan 2008
|
Quarterly Results |
- |
|
18 Oct 2007
|
Quarterly Results |
- |
|
19 Jul 2007
|
Quarterly Results |
- |
|
03 May 2007
|
Audited Results & Dividend |
- |
|
19 Jan 2007
|
To consider issue of warrants |
Issue of 5 million Warrants, convertible into Equity Shares to the Promoter(s) / Promoter Group(s) / Relatives of Promoters. |
|
19 Oct 2006
|
Quarterly Results |
- |
|
27 Jul 2006
|
Quarterly Results |
- |
|
28 Apr 2006
|
Accounts & Dividend |
- |
|
19 Jan 2006
|
Quarterly Results |
- |
|
23 Dec 2005
|
Allotment of 19649 equity shares |
Have allotted 19649 equity shares of Rs 10 each to the employees under ESOP 1999 scheme. |
|
02 Nov 2005
|
Allotment of GDR's |
Has allotted 8,650,000 Global Depositary Receipts at a price of US$ 4.34 per GDR (equivalent to Rs 195 per share), each GDR representing one underlying equity share of Company. |
|
13 Oct 2005
|
Quarterly Results |
- |
|
18 Jul 2005
|
Quarterly Results |
- |
|
15 Jun 2005
|
Issue of GDRs |
In order to meet the further financial outlay on multi-therapeutic expansion and to reduce the interest burden, the Company proposes to raise long term funds by way of issue of GDRs. |
|
27 Apr 2005
|
Dividend & Accounts |
- |
|
20 Jan 2005
|
Quarterly Results |
- |
|
20 Oct 2004
|
Quarterly Results |
- |
|
28 Jul 2004
|
Quarterly Results |
- |
|
25 Apr 2004
|
Dividend & Accounts |
- |
|
16 Mar 2004
|
Others |
To consider raising of long term funds by way of issue of appropriate securities including FCCBs and also issue of warrants to the promoters and associates. |
|
15 Jan 2004
|
Quarterly Results |
- |
|
31 Oct 2003
|
Quarterly Results |
- |
|
24 Jul 2003
|
Quarterly Results |
- |
|
28 Apr 2003
|
Dividend & Accounts |
- |